James Kihara, PRINCIPAL ACCOUNTING OFFICER at ACADIA PHARMACEUTICALS INC (ACAD), sold 8,146 shares at $16.81 ($137K) on 2024-11-19, disclosed to the SEC on 2024-11-19.
Open-market sale of $137k ACAD by PRINCIPAL ACCOUNTING OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.81 | 4,073 | $68K | 50.0% |
| 2 | $16.81 | 4,073 | $68K | 50.0% |
| Total | $16.81 avg | 8,146 | $137K | 100% |
| Filing → |
| ACAD | SELL | 2026-05-05 | $29K | — | Filing → |
| ACAD | SELL | 2026-04-07 | $23K | — | Filing → |
| ACAD | SELL | 2026-03-26 | $42K | — | Filing → |